Nuvectis Pharma, Inc. (NVCT) ownership: Top institutional holder: VANGUARD GROUP INC ($6.38M). Insider activity: Net Seller (9 buys, 11 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| VANGUARD GROUP INC | 845502.00 | $6.38M | 2025-12-31 |
| BlackRock, Inc. | 764441.00 | $5.91M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 659879.00 | $5.10M | 2026-03-31 |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 651757.00 | $5.04M | 2026-03-31 |
| Occam Crest Management LP | 407147.00 | $3.15M | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 384105.00 | $2.97M | 2026-03-31 |
| BALDWIN WEALTH PARTNERS LLC/MA | 378625.00 | $2.93M | 2026-03-31 |
| STATE STREET CORP | 166516.00 | $1.29M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-11 | |
| Sell | null | 2026-06-11 | |
| Sell | null | 2026-06-11 | |
| Sell | null | 2026-06-11 | |
| Sell | null | 2026-01-06 | |
| Sell | null | 2026-01-06 | |
| Sell | null | 2026-01-06 | |
| Sell | null | 2026-01-06 |
Back to NVCT overview · NVCT earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.